“How Do I Stop Checking Things?” Understanding Obsessive-Compulsive Disorder from Neuropsychological Perspective

Ardian Praptomojati
(Submitted 29 January 2018)
(Published 14 June 2019)

Abstract


Obsessive-compulsive disorder (OCD) is the fourth most common mental disorder and WHO classifies it as one of the ten most disabling medical conditions. OCD patients have difficulty in controlling the disturbing thoughts accompanied by ritualistic behavior performed by the patient as a way to reduce anxiety or fear that leads to distress and significant dysfunction in their everyday life. Studies using neuroimaging techniques indicated a number of abnormal functions in the orbitofrontal cortex and caudate nuclei in OCD patients. Abnormalities in one or more neurotransmitters such as serotonin, glutamate, GABA, and dopamine were also found to be associated with the mechanism of the brain circuitry associated with OCD symptoms. Genetic factors were proven to also contribute considerably to OCD. This article is a literature study on OCD, especially from a neuropsychological perspective highlighting the recent development of various techniques and methods of study.

Keywords


abnormality; obsessive-compulsive disorder; neuropsychological perspective

Full Text: PDF

DOI: 10.22146/buletinpsikologi.32807

References


Abramowitz, J. S., & Jacoby, R. J. (2015). Obsessive-compulsive and related disorders: A critical review of the new diagnostic class. Annual Review of Clinical Psychology, 11, 8.1–8.22. doi: 10.1146/annurev-clinpsy-032813-153713

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders fourth edition text revision. Washington, DC: American Psychiatric Association.

American Psychiatric Association. (2007). Practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington, VA: American Psychiatric Association. Retrieved from https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/ocd.pdf

American Psychiatric Association. (2013). Diagnostic and Statistic Manual of Mental Disorders (DSM-5). Arlington, VA: American Psychiatric Association.

Anxiety and Depression Association of America (ADAA). (2014). Obsessive-Compulsive Disorder (OCD). Retrieved from https://adaa.org/sites/default/files/OCD_brochure_rev.2014.pdf

Bartha, R., Stein, M. B., Williamson, P. C., Drost, D. J., Neufeld, R. W. J., Carr, T. J., … Siddiqui, A. R. (1998). A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. The American Journal of Psychiatry, 155(11), 1584–1591.

Bhakoo, K. K. (2012). N-Acetyl-Aspartate (NAA) metabolism. In I.-Y. Choi & R. Gruetter (Ed.), Neural metabolism in vivo, advances in neurobiology 4 (pp. 1075–1093). New York: Springer Science+Business Media, LLC 2012. doi: 10.1007/978-1-4614-1788-0

Blier, P., & Montigny, C. De. (1998). Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive–compulsive disorder responses. Society of Biological Psychiatry, 44, 313–323.

Bobes, J., García-Portilla, M., Bascarán, M., Sáiz, P., Bobes-Bascarán, M., & Bousoño, M. (2007). Quality of life in obsessive-compulsive disorder. In M.S. Ritsner & A. G. Awad (Eds.), Quality of life impairment in schizo­phrenia, mood and anxiety disorders (pp. 293–303). Dordrecht: Springer.

Chamberlain, S. R., Blackwell, A. D., Fineberg, N. A., Robbins, T. W., & Sahakian, B. J. (2005). The neuro­psychology of obsessive compulsive disorder: The importance of failures in cognitive and behavioural inhibition as candidate endopheno­typic markers. Neuroscience and Biobehavioral Reviews, 29, 399–419. doi: 10.1016/j.neubiorev.2004.11.006

Ciesielski, K. T., Matti, S. H., Lesnik, P. G., Geller, D. A., & Ahlfors, S. P. (2005). Increased MEG activation in OCD reflects a compensatory mechanism specific to the phase of a visual working memory task. NeuroImage, 24, 1180–1191. doi: 10.1016/j.neuroimage. 2004.10.018

Comer, R. J. (2010). Abnormal psychology (7th ed.). New York: Worth Publishers.

Dorfman, W. I., & Walker, L. E. A. (2007). First responder’s guide to abnormal psychology: Applications for police, firefighters and rescue personnel. New York: Springer Science_Business Media, LLC.

Durand, V. M., & Barlow, D. H. (2013). Essentials of abnormal psychology (6th ed.). California: Wadsworth Cengage Learning.

Ebert, D., Speck, O., König, A., Berger, M., Hennig, J., & Hohagen, F. (1997). 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Research: Neuroimaging Section, 74, 173–176.

Fineberg, N. A., Saxena, S., Zohar, J., & Craig, K. J. (2011). Obsessive-compulsive disorder: Boundary Issues. In Eric Hollander, J. Zohar, P. J. Sirovatka, & D. A. Regier (Eds.), Obsessive-compulsive spectrum disorders: Refining the research agenda for DSM-V (pp. 1–32). Arlington, Virginia: American Psychiatric Association.

Goodman, W. K., McDougle, C. J., & Price, L. H. (1992). The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder. International Clinical Psychopharma­cology, 7(Suppl. 1), 35–38.

Grootheest, D. S. Van, Cath, D. C., Beekman, A. T., & Boomsma, D. I. (2005). Twin studies on obsessive–compulsive disorder: A review. Twin Research and Human Genetics, 8(5), 450–458.

Grover, S., & Dutt, A. (2011). Perceived burden and quality of life of caregivers in obsessive–compulsive disorder. Psychiatry and Clinical Neurosciences, 65, 416–422. doi: 10.1111/j.1440-1819.2011.02240.x

Hirschtritt, M. E., Bloch, M. H., & Mathews, C. A. (2017). Obsessive-compulsive disorder advances in diagnosis and treatment. JAMA, 317(13), 1358–1367. doi: 10.1001/jama.2017.2200

Hollander, E., Stein, D. J., Kwon, J. H., Rowland, C., Wong, C. M., Broatch, J., & Himelein, C. (1998). Psychosocial function and economic costs of obsessive-compulsive disorder. CNS Spectrums, 3(5[Suppl 1), 48–58.

Insel, T. R., Mueller, E. A., Alterman, I., Linnoila, M., & Murphy, D. L. (1985). Obsessive-compulsive disorder and serotonin: Is there a connection? Biological Psychiatry, 20, 1174–1188.

Jahangard, L., Fadaei, V., Sajadi, A., Haghighi, M., Ahmadpanah, M., Matinnia, N., … Sadeghi, D. (2018). Patients with OCD report lower quality of life after controlling for expert-rated symptoms of depression and anxiety. Psychiatry Research, 260, 318–323. doi: 10.1016/j.psychres. 2017.11.080

Koran, L. M. (2001). Obsessive compulsive disorder and quality of life. In N. Fineberg, D. Marazziti, & D. J. Stein (Eds.), Obsessive compulsive disorder: A practical guide (pp. 51–60). London: Martin Dunitz Ltd.

Krzanowska, E., & Kuleta, M. (2017). From anxiety to compulsivity – a review of changes to OCD classification in DSM-5 and ICD-11. Archives of Psychiatry and Psychotherapy, 3, 7–15. doi: 10.12740/ APP/76150

Kwon, J. S., Jang, J. H., & Kang, D. (2009). Neuroimaging in obsessive – compulsive disorder. Expert Review of Neurotherapeutics, 9(2), 255–269.

Leckman, J. F., Rauch, S. L., & Mataiz-Cols, D. (2011). Symptom dimensions in obsessive-compulsive disorder: Implications for DSM-5. In Eric Hollander, J. Zohar, P. J. Sirovatka, & D. A. Regier (Eds.), Obsessive-compulsive spectrum disorders: Refining the research agenda for DSM-V (pp. 117–140). Arlington, Virginia: American Psychiatric Association.

Lucey, J. V., Costa, D. C., Busatto, G., Pilowsky, L. S., Marks, I. M., Ell, P. J., & Kerwin, R. W. (1997). Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography. Psychiatry Research: Neuroimaging Section, 74, 25–33.

Luxenberg, J. S., Swedo, S. E., Flament, M. F., Friedland, R. P., Rapoport, J., & Rapoport, S. I. (1988). Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative x-ray computed tomography. The American Journal of Psychiatry, 145(9), 1089–1093.

Maihöfner, C., Sperling, W., Kaltenhäuser, M., Bleich, S., Zwaan, M. De, Wiltfang, J., … Ropohl, A. (2007). Spontaneous magnetoencephalographic activity in patients with obsessive-compulsive disorder. Brain Research, 1129, 200–205. doi: 10.1016/j.brainres.2006.10.048

Moutaud, B. (2015). DSM-5 and the reconceptualization of obsessive-compulsive disorder, an anthropological perspective from the neuroscience laboratory. In S. Demazeux & P. Singy (Eds.), The DSM-5 in perspective, history, philosophy and theory of the life sciences 10 (pp. 225–238). Dordrecht: Springer. doi: 10.1007/978-94-017-9765-8

Mundo, E., Zanoni, S., & Altamura, A. C. (2006). Genetic issues in obsessive-compulsive and related disorders. Psychiatric Annals, 36(7), 494–512.

Murray, C. J. L., & Lopez, A. D. (1996). The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health.

Nestadt, G., Lan, T., Samuels, J., Riddle, M., Bienvenu, O. J., Liang, K. Y., … Shugart, Y. Y. (2000). Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. The American Journal of Human Genetics, 67, 1611–1616.

Okada, K., Ota, T., Iida, J., Kishimoto, N., & Kishimoto, T. (2013). Lower prefrontal activity in adults with obsessive–compulsive disorder as measured by near-infrared spec­troscopy. Progress in Neuropsy­chopharmacology & Biological Psychiatry, 43, 7–13. doi: 10.1016/ j.pnpbp.2012.11.013

Ota, T., Iida, J., Sawada, M., Suehiro, Y., Yamamuro, K., Matsuura, H., … Kishimoto, T. (2013). Reduced prefrontal hemodynamic response in pediatric obsessive–compulsive disor­der as measured by near-infrared spectroscopy. Child Psychiatry & Human Development, 44, 265–277. doi: 10.1007/s10578-012-0323-0

Parmar, A., & Sarkar, S. (2016). Neuroimaging studies in obsessive compulsive disorder: A narrative review. Indian Journal of Psychological Medicine, 38, 386–394. doi: 10.4103/ 0253-7176.191395

Pato, M. T., Schindler, K. M., & Pato, C. N. (2001). The genetics of obsessive-compulsive disorder. Current Psychiatry Reports, 3, 163–168.

Pauls, D. L. (2001). The role of genetic factors in OCD. In N. Fineberg, D. Marazziti, & D. J. Stein (Eds.), Obsessive compulsive disorder: A practical guide (pp. 61–75). London: Martin Dunitz Ltd.

Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014). Obsessive – compulsive disorder: An integrative genetic and neurobiological pers­pective. Nature Reviews Neuroscience, 15, 410–425. doi: 10.1038/ nrn3746

Pauls, D. L., Mundo, E., & Kennedy, J. L. (2002). The pathophysiology and genetics of obsessive-compulsive disorder. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress: An official publication of the American College of Neuropsychopharmacology (pp. 1609–1619). Philadelphia: Lippincott, Williams, & Wilkins.

Remmerswaal, K. C. P., Batelaan, N. M., Smit, J. H., Oppen, P. Van, & Balkom, A. J. L. M. Van. (2016). Quality of life and relationship satisfaction of patients with Obsessive Compulsive Disorder. Journal of Obsessive-Compulsive and Related Disorders, 11, 56–62. doi: 10.1016/j.jocrd.2016.08.005

Robinson, D., Wu, H., Munne, R. A., Ashtari, M., Alvir, J. M. J., Lerner, G., … Bogerts, B. (1995). Reduced caudate nucleus volume in obsessive-compulsive disorder. Archives of General Psychiatry, 52, 393–398.

Sahoo, P., Sethy, R. R., & Ram, D. (2017). Functional impairment and quality of life in patients with obsessive compulsive disorder. Indian Psychiatric Society, 39(6), 760–765. doi: 10.4103/IJPSYM.IJPSYM_53_17

Saxena, S., & Rauch, S. L. (2000). Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. The Psychiatric Clinics of North America, 23(3), 563–586.

Schwartzman, C. M., Boisseau, C. L., Eisen, J. L., Rasmussen, S. A., Sibrava, N. J., & Mancebo, M. C. (2017). Symptom subtype and quality of life in obsessive-compulsive disorder. Psychiatry Research, 249, 307–310. doi: 10.1016/j.psychres.2017.01.025

Sharma, A. (2011). Regional cerebral blood flow. In Kreutzer J. S., Deluca J., & Caplan B. (Eds.), Encyclopedia of Clinical Neuropsychology (pp. 2135–2136). New York: Springer. doi: 10.1007/978-0-387-79948-3

Stein, D. J., Kogan, C. S., Atmaca, M., Fineberg, N. A., Fontenelle, L. F., Grant, J. E., … Reed, G. M. (2016). The classification of obsessive-compulsive and related disorders in the ICD-11. Journal of Affective Disorders, 190, 663–674. doi: 10.1016/j.jad.2015.10.061

Stengler-Wenzke, K., Kroll, M., Matschinger, H., & Angermeyer, M. C. (2006). Subjective quality of life of patients with obsessive – compulsive disorder. Social Psychiatry and Psychiatric Epidemiology, 41, 662–668. doi: 10.1007/s00127-006-0077-8

Szeszko, P. R., Ardekani, B. A., Ashtari, M., Malhotra, A. K., Robinson, D. G., Bilder, R. M., & Lim, K. O. (2005). White matter abnormalities in obsessive-compulsive disorder: A diffusion tensor imaging study. Archieves of General Psychiatry, 62, 782–790.

Taylor, S. (2013). Molecular genetics of obsessive-compulsive disorder: A comprehensive meta-analysis of genetic association studies. Molecular Psychiatry, 18, 799–805. doi: 10.1038/ mp.2012.76

Vikas, A., Avasthi, A., & Sharan, P. (2011). Psychosocial impact of obsessive-compulsive disorder on patients and their caregivers: A comparative study with depressive disorder. International Journal of Social Psychiatry, 57(1), 45–56. doi: 10.1177/0020764009347333

Vivan, A. D. S., Rodrigues, L., Wendt, G., & Bicca, M. G. (2013). Quality of life in adolescents with obsessive-compulsive disorder. Revista Brasileira de Psiquiatria, 35, 369–374.

Vulink, N. C. C., Denys, D., & Westenberg, H. G. M. (2006). Female hormones affect symptom severity in obsessive–compulsive disorder. International Clinical Psychopharmacology, 21, 171–175.

World Health Organization. (2008). The global burden of disease: 2004 update. Geneva: WHO Press.

Wu, M. S., Hamblin, R., Nadeau, J., Simmons, J., Smith, A., Wilson, M., … Storch, E. A. (2018). Quality of life and burden in caregivers of youth with obsessive-compulsive disorder presenting for intensive treatment. Comprehensive Psychiatry, 80, 46–56. doi: 10.1016/j.comppsych.2017.08.005


Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Buletin Psikologi

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.